What is the treatment for yeast in urine, specifically a Candida urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Candida Urinary Tract Infections

For symptomatic Candida urinary tract infections, oral fluconazole at a dosage of 200 mg (3 mg/kg) daily for 2 weeks is the recommended first-line treatment for fluconazole-susceptible species. 1

Treatment Algorithm Based on Clinical Presentation

Asymptomatic Candiduria

  • Treatment is generally not recommended unless the patient belongs to a high-risk group 1, 2
  • High-risk groups requiring treatment:
    • Neutropenic patients
    • Very low-birth-weight infants
    • Patients undergoing urologic procedures 1, 2
  • For patients undergoing urologic procedures:
    • Fluconazole 200-400 mg daily OR
    • Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for several days before and after the procedure 1

Symptomatic Candida UTIs

  1. For Candida cystitis (lower UTI):

    • Fluconazole-susceptible species: Oral fluconazole 200 mg daily for 2 weeks 1, 3
    • Fluconazole-resistant species (including C. krusei):
      • Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days OR
      • Oral flucytosine 25 mg/kg 4 times daily for 7-10 days 1, 2
  2. For Candida pyelonephritis (upper UTI):

    • Fluconazole-susceptible species: Oral fluconazole 200-400 mg daily for 2 weeks 1
    • Fluconazole-resistant species:
      • Amphotericin B deoxycholate 0.5-0.7 mg/kg daily with or without flucytosine 25 mg/kg 4 times daily OR
      • Flucytosine alone at 25 mg/kg 4 times daily for 2 weeks 1
  3. For fungus balls:

    • Surgical intervention is strongly recommended in non-neonates 1, 2
    • Plus systemic antifungal therapy:
      • Fluconazole 200-400 mg daily OR
      • Amphotericin B deoxycholate 0.5-0.7 mg/kg daily with or without flucytosine 1
    • If access to renal collecting system is available, irrigation with Amphotericin B deoxycholate (50 mg/L sterile water) 1, 2

Important Management Considerations

Elimination of Predisposing Factors

  • Remove indwelling urinary catheters if present
  • Discontinue unnecessary antibiotics
  • Address urinary tract obstruction if present 1, 2, 4
  • Removing these factors alone resolves candiduria in approximately 50% of cases 2, 5

Antifungal Selection Considerations

  • Fluconazole: Achieves high urinary concentrations and is the drug of choice for susceptible species 3, 4, 5
  • Amphotericin B deoxycholate: Effective alternative for fluconazole-resistant species, achieving high urinary concentrations 2
  • Avoid:
    • Echinocandins (caspofungin, micafungin, anidulafungin) due to poor urinary concentrations 2, 5
    • Newer azoles (voriconazole, posaconazole) due to poor urinary concentrations 2
    • Lipid formulations of amphotericin B for lower UTIs 2

Treatment Duration

  • Continue treatment for 2 weeks or until symptoms resolve and urine cultures become negative 1, 2
  • Obtain follow-up urine cultures to confirm eradication 2

Common Pitfalls to Avoid

  1. Treating asymptomatic candiduria unnecessarily in low-risk patients 2
  2. Failing to remove indwelling catheters or address underlying conditions 2, 5
  3. Using antifungals with poor urinary concentrations (echinocandins, newer azoles) for uncomplicated UTIs 2, 5
  4. Using flucytosine as monotherapy due to risk of resistance development 2
  5. Not distinguishing between colonization and true infection 2, 4

By following this evidence-based approach, clinicians can effectively manage Candida urinary tract infections while avoiding unnecessary treatment in cases of asymptomatic candiduria.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Fungal Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Candida urinary tract infections in adults.

World journal of urology, 2020

Research

Candida urinary tract infections: treatment options.

Expert review of anti-infective therapy, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.